SHANGHAI, Sep. 4 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced that the Company's management team will attend the Susquehanna International Group of Companies ("SIG") 3rd Annual Beijing Management Summit.

The SIG 3rd Annual Beijing Management Summit a two-day conference that brings together executives from public and private companies based in China and other emerging Asian economies. The event will showcase leading companies in the Chinese Consumer, Health Care, Internet, and Technology sectors, as well as companies in the IT Services/Outsourcing and Financial Technologies sectors. The event format will consist of one-on-one meetings and company presentations.

The date and location of China-Biotics' one-to-one meetings at the SIG 3rd Annual Beijing Management Summit are as follows:

    Date:         September 16 and September 17, 2009
    Management:   Mr. Lewis Fan, Chief Financial Officer
    Venue:        The Grand Hyatt Beijing Hotel
                  1 East Chang An Avenue
                  Beijing 100738

During the conference, the management will be available to meet with analysts and portfolio managers. Interested parties and investors who wish to meet with China-Biotics management may contact vivian.chen@ccgir.com or call (310) 926-8038. Participation in the SIG 3rd Annual Beijing Management Summit is by invitation only.

About China-Biotics, Inc.

China-Biotics, Inc. ("China-Biotics," "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements. Through its wholly owned subsidiary, Shanghai Shining Biotechnology Co., Ltd., the Company has operations in Shanghai. Its proprietary product portfolio contains live microbial nutritional supplements under the "Shining" brand. Currently, the products are sold OTC through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang. China-Biotics plans to launch 300 Shining brand retail outlets in major cities in China. Currently, China-Biotics is strategically expanding its production capacity of probiotics to meet growing demand in the bulk additive market. For more information, please visit http://www.chn-biotics.com .

    For more information, please contact:

     Lewis Fan, CFO
     China-Biotics, Inc.
     Email: lewisfan@chn-biotics.com
     Web:   http://www.chn-biotics.com

    CCG Investor Relations
     Crocker Coulson, President
     Phone: +1-646-213-1915 (New York)
     Email: crocker.coulson@ccgir.com
     Web:   http://www.ccgirasia.com

SOURCE China-Biotics, Inc.

Back to top

RELATED LINKS
http://www.chn-biotics.com